Mirabegron in Achalasia: A Clinical and Manometric Proof of Concept Pilot Study
Status:
Terminated
Trial end date:
2019-12-15
Target enrollment:
Participant gender:
Summary
This study evaluates whether a medication called mirabegron is better than placebo (sugar
pill) in helping patients with achalasia swallow better. Each patient will receive either
mirabegron or the placebo for 4 weeks followed by the opposite medication. Each patient will
complete several surveys and undergo several tests to determine if the mirabegron is helping
reduce the pressures in the esophagus (swallowing tube).